COMPREHENSIVE BIOMARKER CT GMBH has a total of 20 patent applications. Its first patent ever was published in 2010. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets biotechnology, medical technology and computer technology are SOURCE PREC MEDICINE INC D B A, NIPD GENETICS LTD and BANKAITIS-DAVIS DANUTE M.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 9 | |
#2 | EPO (European Patent Office) | 7 | |
#3 | United States | 3 | |
#4 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Medical technology | |
#3 | Computer technology | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Electrotherapy | |
#3 | Peptides | |
#4 | Climate change adaptation technologies | |
#5 | Bioinformatics |
# | Name | Total Patents |
---|---|---|
#1 | Beier Markus | 19 |
#2 | Keller Andreas | 11 |
#3 | Meder Benjamin | 6 |
#4 | Katus Hugo | 5 |
#5 | Vogel Britta | 5 |
#6 | Borries Anne | 4 |
#7 | Meese Eckart | 4 |
#8 | Scheffler Matthias | 4 |
#9 | Ingwersen Jens | 3 |
#10 | Aktas Orhan | 3 |
Publication | Filing date | Title |
---|---|---|
WO2015091897A1 | Determination of platelet-mirnas | |
WO2015091907A1 | Determination of platelet-mirnas in heart failure | |
WO2015091963A2 | Determination of platelet-mirnas in acute myocardial infarction | |
WO2015091892A1 | Mirnas as non-invasive biomarkers for parkinson's disease | |
US2016194712A1 | Mirna based treatment monitoring in autoimmune diseases | |
WO2014187884A2 | Mirnas as non-invasive biomarkers for heart failure | |
EP2668288A2 | Complex mirna sets as novel biomarkers for lung diseases | |
EP2561091A1 | Complex mirna sets as novel biomarkers for an acute coronary syndrome |